The IPO was a mix of a fresh issue of shares aggregating to ₹455 crore and an offer for sale of up to ₹300 crore. On Tuesday, the company raised ₹226 crore from anchor investors ahead of its public issue by allotting 68.41 lakhs shares to institutions.
Amish Shah turns bullish on pharma, remains cautious on IT
Indian equities are poised for a constructive phase, with strategists anticipating earnings acceleration and a potential revival in foreign investor interest. While near-term earnings surprises